title: Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
authors.affiliation: Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts2Havard Medical School, Boston, Massachusetts.
authors.forename: Laura E
authors.initials: LE
authors.lastname: MacConaill
authors.affiliation: Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts2Havard Medical School, Boston, Massachusetts.
authors.forename: Neal I
authors.initials: NI
authors.lastname: Lindeman
authors.affiliation: Havard Medical School, Boston, Massachusetts3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
authors.forename: Barrett J
authors.initials: BJ
authors.lastname: Rollins
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D004059:Diffusion of Innovation; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000639:trends*; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D018579:Patient Selection; D010641:Phenotype; D057285:Precision Medicine / Q000639:trends*; D011237:Predictive Value of Tests; D011379:Prognosis; D015203:Reproducibility of Results
chemical_list: D014408:Biomarkers, Tumor